These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24335299)

  • 81. MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.
    Muñoz-Alía MÁ; Nace RA; Tischer A; Zhang L; Bah ES; Auton M; Russell SJ
    PLoS Pathog; 2021 Feb; 17(2):e1009283. PubMed ID: 33534834
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Physical association of moesin and CD46 as a receptor complex for measles virus.
    Schneider-Schaulies J; Dunster LM; Schwartz-Albiez R; Krohne G; ter Meulen V
    J Virol; 1995 Apr; 69(4):2248-56. PubMed ID: 7884872
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Adaptation of wild-type measles virus to tissue culture.
    Kouomou DW; Wild TF
    J Virol; 2002 Feb; 76(3):1505-9. PubMed ID: 11773423
    [TBL] [Abstract][Full Text] [Related]  

  • 84. CD46- and CD150-independent endothelial cell infection with wild-type measles viruses.
    Andres O; Obojes K; Kim KS; Meulen VT; Schneider-Schaulies J
    J Gen Virol; 2003 May; 84(Pt 5):1189-1197. PubMed ID: 12692284
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Structure of measles virus hemagglutinin bound to its epithelial receptor nectin-4.
    Zhang X; Lu G; Qi J; Li Y; He Y; Xu X; Shi J; Zhang CW; Yan J; Gao GF
    Nat Struct Mol Biol; 2013 Jan; 20(1):67-72. PubMed ID: 23202587
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity.
    Ayala Breton C; Wikan N; Abbuhl A; Smith DR; Russell SJ; Peng KW
    Mol Ther Oncolytics; 2015; 2():15012. PubMed ID: 27119107
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The human CD46 molecule is a receptor for measles virus (Edmonston strain).
    Dörig RE; Marcil A; Chopra A; Richardson CD
    Cell; 1993 Oct; 75(2):295-305. PubMed ID: 8402913
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Receptor (CD46)- and replication-mediated interleukin-6 induction by measles virus in human astrocytoma cells.
    Ghali M; Schneider-Schaulies J
    J Neurovirol; 1998 Oct; 4(5):521-30. PubMed ID: 9839649
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors.
    Dhiman N; Poland GA; Cunningham JM; Jacobson RM; Ovsyannikova IG; Vierkant RA; Wu Y; Pankratz VS
    J Allergy Clin Immunol; 2007 Sep; 120(3):666-72. PubMed ID: 17560639
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mutations in the putative dimer-dimer interfaces of the measles virus hemagglutinin head domain affect membrane fusion triggering.
    Nakashima M; Shirogane Y; Hashiguchi T; Yanagi Y
    J Biol Chem; 2013 Mar; 288(12):8085-8091. PubMed ID: 23362271
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus).
    Pfeuffer J; Püschel K; Meulen Vt; Schneider-Schaulies J; Niewiesk S
    J Virol; 2003 Jan; 77(1):150-8. PubMed ID: 12477820
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.
    Murakami Y; Seya T; Kurita M; Fukui A; Ueda S; Nagasawa S
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1351-9. PubMed ID: 9494106
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Morbillivirus downregulation of CD46.
    Galbraith SE; Tiwari A; Baron MD; Lund BT; Barrett T; Cosby SL
    J Virol; 1998 Dec; 72(12):10292-7. PubMed ID: 9811778
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Role of CD46 in measles virus infection in CD46 transgenic mice.
    Blixenkrone-Møller M; Bernard A; Bencsik A; Sixt N; Diamond LE; Logan JS; Wild TF
    Virology; 1998 Sep; 249(2):238-48. PubMed ID: 9791016
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.
    Lühl NC; Zirngibl F; Dorneburg C; Wei J; Dahlhaus M; Barth TF; Meyer LH; Queudeville M; Eckhoff S; Debatin KM; Beltinger C
    Haematologica; 2014 Jun; 99(6):1050-61. PubMed ID: 24700491
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding.
    Hsu EC; Dörig RE; Sarangi F; Marcil A; Iorio C; Richardson CD
    J Virol; 1997 Aug; 71(8):6144-54. PubMed ID: 9223509
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys.
    Leonard VH; Hodge G; Reyes-Del Valle J; McChesney MB; Cattaneo R
    J Virol; 2010 Apr; 84(7):3413-20. PubMed ID: 20071568
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling.
    Xia M; Gonzalez P; Li C; Meng G; Jiang A; Wang H; Gao Q; Debatin KM; Beltinger C; Wei J
    J Virol; 2014 May; 88(9):5152-64. PubMed ID: 24574393
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Measles vaccine strains for virotherapy of non-small-cell lung carcinoma.
    Patel MR; Jacobson BA; Belgum H; Raza A; Sadiq A; Drees J; Wang H; Jay-Dixon J; Etchison R; Federspiel MJ; Russell SJ; Kratzke RA
    J Thorac Oncol; 2014 Aug; 9(8):1101-10. PubMed ID: 25157763
    [TBL] [Abstract][Full Text] [Related]  

  • 100. p53 regulates CD46 expression and measles virus infection in myeloma cells.
    Lok A; Descamps G; Tessoulin B; Chiron D; Eveillard M; Godon C; Le Bris Y; Vabret A; Bellanger C; Maillet L; Barillé-Nion S; Gregoire M; Fonteneau JF; Le Gouill S; Moreau P; Tangy F; Amiot M; Moreau-Aubry A; Pellat-Deceunynck C
    Blood Adv; 2018 Dec; 2(23):3492-3505. PubMed ID: 30530776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.